ClinicalTrials.gg
CompletedNCT00468650Updated Feb 18, 2021Results posted

A Multicenter, Open Label, To Evaluate The Efficacy And Satisfaction Of Patrex® In Men With Erectile Dysfunction.

A Phase 4 interventional study of sildenafil citrate in Erectile Dysfunction, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris Inc.. Completed at 10 sites in Mexico. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-02-18.

Sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (part of Viatris Inc.) · Phase 4, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
117
Allocation
Non-randomized
Ages
18 Years and older
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 50 studies testing sildenafil in Erectile Dysfunction — 1 open to participants now, 1 under way, 1 of them phase 3. sildenafil · Erectile Dysfunction.

Enrollment
24th of 50
117 · median 108
Started
2007
with 1 other
Phase 4
30 of 50
none open now
Registered
19th of 50
by date
Lead sponsor
23 of 50
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Among the 50 studies testing sildenafil in Erectile Dysfunction, this one is the 24th largest by enrollment, is one of 2 that started in 2007, is one of 30 in phase 4, and was the 19th registered.

Erectile Dysfunction

702 studies on the registry are indexed under Erectile Dysfunction; 125 are open to participants now.

Browse Erectile Dysfunction studies →

Open to participants now

1 of the 50 studies testing sildenafil in Erectile Dysfunction is open now. Recruiting first, the newest first:

About sildenafil

sildenafil: first FDA approval 1998 (VIAGRA), first EMA approval 1998. What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 78 Erectile Dysfunction studies recruiting now, 31 (40%) set no upper age limit and 34 (44%) stop at 75 or younger; 2 take children under 18; 7 take healthy volunteers.

This study: 18 Years and older · male · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 50 studies testing sildenafil in Erectile Dysfunction, or all of them as a file.
02

Study summary

A multicenter open label study to assess the efficacy of sildenafil rapid dose titration to 100 mg in men with erectile dysfunction, based on the Erectile Function (EF) domain score of the International Index of Erectile Function (IIEF) questionnaire.

03

Conditions studied

  • Erectile Dysfunction

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Documented Clinical diagnosis of Erectile Dysfunction (ED) by International Index of Erectile Function (IIEF) Erectile Function (EF) Domain score less than or equal to 25.
  • Subjects must be in a stable relationship

Exclusion criteria

Exclusion Criteria:

  • Subject with resting sitting hypotension (BP \<90/50 mmHg) or hypertension (BP>170/110 mmHg) and orthostatic hypotension.
  • Subjects receiving any PDE (Phosphodiesterase)-5 inhibitors within 4 weeks prior to the date of screening.
  • Subjects with severe hepatic impairment, a known history of retinitis pigmentare.
  • Subjects with significant cardiovascular disease in the last 3 months (per medical history.
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
117 participants (actual)

Study arms

  • Active comparator
    Open label

    Eligible patients fulfilling all inclusion/exclusion criteria will be assigned at Visit 2/Week 0 (Baseline) to receive Patrex® 50 mg as needed (PRN) during the first two weeks, and,thereafter, at Visit 3/Week 2, all enrolled subjects will be up titrated to Patrex® 100 mg PRN for the following four weeks.

    Drug: sildenafil citrate

Interventions

  • Tablets, 50mg and 100mg , Medication will be taken orally with a glass of water approximately one hour (30 min to 4 hours) before sexual activity. Subjects are to take one dose in any calendar day.Eligible patients fulfilling all inclusion/exclusion criteria will be assigned at Visit 2/Week 0 (Baseline) to receive sildenafil 50 mg as needed (PRN) during the first two weeks, and,thereafter, at Visit 3/Week 2, all enrolled subjects will be up titrated to sildenafil 100 mg PRN for the following four weeks.

06

What researchers measure

Primary outcomes

  1. International Index of Erectile Function (IIEF), Erectile Function (EF) Domain Score- Change From Baseline to Week 6 Last Observation Carried Forward (LOCF)

    IIEF is a self-administered scale designed to assess erectile functioning: includes 15 questions on 5 relevant domains of male sexual function; one is erectile function (EF). IIEF-EF Domain: sum of scores for Questions 1, 2, 3, 4, 5 \& 15 from IIEF. Score range: 0 to 5 (Q1 to Q5), 1 to 5 (Q15); total 1 to 30. Higher score indicates better outcome.

    Time frame: Week 6 LOCF

Secondary outcomes

  1. International Index of Erectile Function (IIEF), Erectile Function (EF) Domain Score - Change From Baseline at Weeks 2, 4 and 6

    IIEF is a self-administered scale designed to assess erectile functioning: includes 15 questions on 5 relevant domains of male sexual function; one is erectile function (EF). IIEF-EF Domain: sum of scores for Questions 1, 2, 3, 4, 5 \& 15 from IIEF. Score range: 0 to 5 (Q1 to Q5), 1 to 5 (Q15); total 1 to 30. Higher score indicates better outcome.

    Time frame: Week 2, Week 4 and Week 6

  2. International Index of Erectile Function (IIEF), Erectile Function (EF) Domain Score- Change From Week 2

    IIEF is a self-administered scale designed to assess erectile functioning: includes 15 questions on 5 relevant domains of male sexual function; one is erectile function (EF). IIEF-EF Domain: sum of scores for Questions 1, 2, 3, 4, 5 \& 15 from IIEF. Score range: 0 to 5 (Q1 to Q5), 1 to 5 (Q15); total 1 to 30. Higher score indicates better outcome.

    Time frame: Week 4 and Week 6

  3. International Index of Erectile Function (IIEF), Orgasmic Function Domain- Change From Baseline

    IIEF is a self-administered scale to assess erectile functioning. IIEF includes 15 questions and addresses the 5 relevant domains of male sexual function, one is orgasmic function. IIEF Orgasmic Function Domain was sum of scores for Questions 9 and 10 from the IIEF. Score range: 0 to 5; total 0 to 10. Higher score indicates better outcome.

    Time frame: Week 2, Week 4 and Week 6

  4. International Index of Erectile Function (IIEF), Orgasmic Function Domain- Change From Week 2

    IIEF is a self-administered scale to assess erectile functioning. IIEF includes 15 questions and addresses the 5 relevant domains of male sexual function, one is orgasmic function. IIEF Orgasmic Function Domain was sum of scores for Questions 9 and 10 from the IIEF. Score range: 0 to 5; total 0 to 10. Higher score indicates better outcome.

    Time frame: Week 4 and Week 6

  5. International Index of Erectile Function (IIEF), Sexual Desire Domain Score- Change From Baseline

    IIEF is a self-administered scale to assess erectile functioning. IIEF includes 15 questions and addresses the 5 relevant domains of male sexual function, one of which is sexual desire. IIEF Sexual Desire Domain was sum of scores for Questions 11 and 12 from the IIEF. Score range: 1 to 5; total 2 to 10. Higher score indicates better outcome.

    Time frame: Week 2, Week 4 and Week 6

  6. International Index of Erectile Function (IIEF), Sexual Desire Domain Score- Change From Week 2

    IIEF is a self-administered scale to assess erectile functioning. IIEF includes 15 questions and addresses the 5 relevant domains of male sexual function, one of which is sexual desire. IIEF Sexual Desire Domain was sum of scores for Questions 11 and 12 from the IIEF. Score range: 1 to 5; total 2 to 10. Higher score indicates better outcome.

    Time frame: Week 4 and Week 6

  7. International Index of Erectile Function (IIEF), Intercourse Satisfaction Domain Score- Change From Baseline

    IIEF is a self-administered scale to assess erectile functioning. IIEF includes 15 questions and addresses the 5 relevant domains of male sexual function, one is intercourse satisfaction. IIEF Intercourse Satisfaction Domain: sum of scores for Questions 6, 7 and 8 from IIEF. Score range: 0 to 5; total 0 to 15. Higher score indicates better outcome.

    Time frame: Week 2, Week 4, and Week 6

  8. International Index of Erectile Function (IIEF), Intercourse Satisfaction Domain Score- Change From Week 2

    IIEF is a self-administered scale to assess erectile functioning. IIEF includes 15 questions and addresses the 5 relevant domains of male sexual function, one is intercourse satisfaction. IIEF Intercourse Satisfaction Domain: sum of scores for Questions 6, 7 and 8 from IIEF. Score range: 0 to 5; total 0 to 15. Higher score indicates better outcome.

    Time frame: Week 4 and Week 6

  9. International Index of Erectile Function (IIEF), Overall Satisfaction Domain Score- Change From Baseline

    IIEF is a self-administered scale to assess erectile functioning. IIEF includes 15 questions and addresses the 5 relevant domains of male sexual function, one is overall satisfaction. IIEF Overall Satisfaction Domain was sum of scores for Questions 13 and 14 from the IIEF. Score range: 1 to 5; total 2 to 10. Higher score indicates better outcome.

    Time frame: Week 2, Week 4 and Week 6

  10. International Index of Erectile Function (IIEF), Overall Satisfaction Domain Score- Change From Week 2

    IIEF is a self-administered scale to assess erectile functioning. IIEF includes 15 questions and addresses the 5 relevant domains of male sexual function, one is overall satisfaction. IIEF Overall Satisfaction Domain was sum of scores for Questions 13 and 14 from the IIEF. Score range: 1 to 5; total 2 to 10. Higher score indicates better outcome.

    Time frame: Week 4 and Week 6

  11. Quality of Erection Questionnaire (QEQ): Total Score - Change From Baseline

    QEQ is a self-administered scale used to assess erection hardness and overall quality of erections. The QEQ total score is defined as the sum of the scores from QEQ Questions 1-6. Score range: 1 to 5. Higher score indicates better outcome. Raw QEQ score ranges from 6-30 and is transformed onto a 0-100 scale.

    Time frame: Week 2, Week 4, and Week 6

  12. Quality of Erection Questionnaire (QEQ): Total Score- Change From Week 2

    QEQ is a self-administered scale used to assess erection hardness and overall quality of erections. The QEQ total score is defined as the sum of the scores from QEQ Questions 1-6. Score range: 1 to 5. Higher score indicates better outcome. Raw QEQ score ranges from 6-30 and is transformed onto a 0-100 scale.

    Time frame: Week 4 and Week 6

  13. Sexual Experience Questionnaire (Sex-Q): Erection Domain - Change From Baseline

    Sexual Experience Questionnaire (Sex-Q) is a self-administered questionnaire designed to assess functional, emotional, and social aspects of sexual experience. Sex-Q includes 15 questions. Sex-Q Erection domain: sum of scores for Questions 1, 2, 3, 4, 5 and 6 from the Sex-Q. Score range: 1 to 5; total 6 to 30. Higher score indicates better outcome.

    Time frame: Week 2, Week 4 and Week 6

  14. Sexual Experience Questionnaire (Sex-Q): Erection Domain- Change From Week 2

    Sexual Experience Questionnaire (Sex-Q) is a self-administered questionnaire designed to assess functional, emotional, and social aspects of sexual experience. Sex-Q includes 15 questions. Sex-Q Erection domain: sum of scores for Questions 1, 2, 3, 4, 5 and 6 from the Sex-Q. Score range: 1 to 5; total 6 to 30. Higher score indicates better outcome.

    Time frame: Week 4 and Week 6

  15. Sexual Experience Questionnaire (Sex-Q): Satisfaction Domain - Change From Baseline

    Sexual Experience Questionnaire (Sex-Q) is a self-administered questionnaire designed to assess functional, emotional, and social aspects of sexual experience. Sex-Q includes 15 questions (q). Sex-Q Satisfaction domain:sum of scores for q 10, 11, 12, 13, 14 and 15 from Sex-Q. Score range:1 to 5; total 6 to 30. Higher score indicates better outcome

    Time frame: Week 2, Week 4, and Week 6

  16. Sexual Experience Questionnaire (Sex-Q): Satisfaction Domain - Change From Week 2

    Sexual Experience Questionnaire (Sex-Q) is a self-administered questionnaire designed to assess functional, emotional, and social aspects of sexual experience. Sex-Q includes 15 questions (q). Sex-Q Satisfaction domain:sum of scores for q 10, 11, 12, 13, 14 and 15 from Sex-Q. Score range:1 to 5; total 6 to 30. Higher score indicates better outcome

    Time frame: Week 4 and Week 6

  17. Sexual Experience Questionnaire (Sex-Q): Relationship Domain - Change From Baseline

    Sexual Experience Questionnaire (Sex-Q) is a self-administered questionnaire designed to assess functional, emotional, and social aspects of sexual experience. Sex-Q includes 15 questions. Sex-Q Relationship domain was sum of scores for Questions 7, 8 and 9 from the Sex-Q. Score range: 1 to 5; total 3 to 15. Higher score indicates better outcome.

    Time frame: Week 2, Week 4, and Week 6

  18. Sexual Experience Questionnaire (Sex-Q): Relationship Domain - Change From Week 2

    Sexual Experience Questionnaire (Sex-Q) is a self-administered questionnaire designed to assess functional, emotional, and social aspects of sexual experience. Sex-Q includes 15 questions. Sex-Q Relationship domain was sum of scores for Questions 7, 8 and 9 from the Sex-Q. Score range: 1 to 5; total 3 to 15. Higher score indicates better outcome.

    Time frame: Week 4 and Week 6

  19. Mean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 1 on Occasions With Sexual Stimulation- Change From Baseline

    Mean change: mean change at each visit minus mean at baseline. Percent of "Yes" responses to Question 1 based on occasions (= sexual stimulation): 100\*(number of occasions where SEP Question 1 \[Were you able to achieve at least some erection (some enlargement of the penis)?\] = Yes) / (number of occasions where Question 1 was answered Yes or No)

    Time frame: Week 2, Week 4 and Week 6

  20. Mean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 1 Based on Occasions With Sexual Stimulation- Change From Week 2

    Mean change: mean change at each visit minus mean at Week 2. Percent of "Yes" responses to Question 1 based on occasions (= sexual stimulation): 100\*(number of occasions where SEP Question 1 \[Were you able to achieve at least some erection (some enlargement of the penis)?\] = Yes) / (number of occasions where Question 1 was answered Yes or No)

    Time frame: Week 4 and Week 6

  21. Mean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 2 on Occasions With Sexual Stimulation- Change From Baseline

    Mean change: mean change at each visit minus mean at baseline. Percent of "Yes" responses to SEP Question 2 based on occasions (= sexual stimulation): 100\*(number of occasions where SEP Question 2 \["Were you able to insert your penis into your partner's vagina?"\] = "Yes") / (number of occasions where SEP Question 2 was answered "Yes" or "No").

    Time frame: Week 2, Week 4 and Week 6

  22. Mean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 2 on Occasions With Sexual Stimulation- Change From Week 2

    Mean change: mean change at each visit minus mean at Week 2. Percent of "Yes" responses to SEP Question 2 based on occasions (= sexual stimulation): 100\*(number of occasions where SEP Question 2 \["Were you able to insert your penis into your partner's vagina?"\] = "Yes") / (number of occasions where SEP Question 2 was answered "Yes" or "No").

    Time frame: Week 4 and Week 6

  23. Mean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 3 on Occasions With Sexual Stimulation- Change From Baseline

    Mean change: mean change at each visit minus mean at baseline. Percent of "Yes" responses to SEP Question 2 based on occasions (= sexual stimulation): 100\*(number of occasions where SEP Question 3 \[Did your erection last long enough for you to have successful intercourse?\] = Yes) / (number of occasions where SEP Question 3 was answered Yes or No)

    Time frame: Week 2, Week 4 and Week 6

  24. Mean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 3 Based on Occasions With Sexual Stimulation- Change From Week 2

    Mean change: mean change at each visit minus mean at Week 2. Percent of "Yes" responses to SEP Question 2 based on occasions (= sexual stimulation): 100\*(number of occasions where SEP Question 3 \[Did your erection last long enough for you to have successful intercourse?\] = Yes) / (number of occasions where SEP Question 3 was answered Yes or No)

    Time frame: Week 4 and Week 6

  25. Mean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 4 Based on Occasions With Sexual Stimulation- Change From Baseline

    Mean change: mean change at each visit minus mean at baseline. Percent of "Yes" responses to SEP Question 4 based on occasions (= sexual stimulation): 100\*(number of occasions where SEP Question 4 \["Were you satisfied with the hardness of your erection?"\] = "Yes") / (number of occasions where SEP Question 4 was answered "Yes" or "No").

    Time frame: Week 2, Week 4 and Week 6

  26. Mean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 4 Based on Occasions With Sexual Stimulation- Change From Week 2

    Mean change: mean change at each visit minus mean at Week 2. Percent of "Yes" responses to SEP Question 4 based on occasions (= sexual stimulation): 100\*(number of occasions where SEP Question 4 \["Were you satisfied with the hardness of your erection?"\] = "Yes") / (number of occasions where SEP Question 4 was answered "Yes" or "No").

    Time frame: Week 4 and Week 6

  27. Mean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 5 Based on Occasions With Sexual Stimulation- Change From Baseline

    Mean change: mean change at each visit minus mean at baseline. Percent of "Yes" responses to SEP Question 5 based on occasions (= sexual stimulation): 100\*(number of occasions where SEP Question 5 \["Were you satisfied with this sexual encounter?"\] = "Yes") / (number of occasions where SEP Question 5 was answered "Yes" or "No")

    Time frame: Week 2, Week 4 and Week 6

  28. Mean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 5 Based on Occasions With Sexual Stimulation- Change From Week 2

    Mean change: mean change at each visit minus mean at Week 2. Percent of "Yes" responses to SEP Question 5 based on occasions (= sexual stimulation): 100\*(number of occasions where SEP Question 5 \["Were you satisfied with this sexual encounter?"\] = "Yes") / (number of occasions where SEP Question 5 was answered "Yes" or "No")

    Time frame: Week 4 and Week 6

  29. Mean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 3 (Q3) Based on Attempts With Sexual Stimulation- Change From Baseline

    Mean change: mean change at each visit minus mean at baseline. Percent of "Yes" responses to SEP Q3 based on attempts with sexual stimulation (SS): 100\* (number of attempts with SS where SEP Q3 \[Did your erection last long enough for you to have successful intercourse?\] = Yes)/(number of attempts with SS where SEP Q3 was answered Yes or No)

    Time frame: Week 2, Week 4, and Week 6

  30. Mean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 3 (Q3) Based on Attempts With Sexual Stimulation- Change From Week 2

    Mean change: mean change at each visit minus mean at Week 2. Percent of "Yes" responses to SEP Q3 based on attempts with sexual stimulation (SS): 100\* (number of attempts with SS where SEP Q3 \[Did your erection last long enough for you to have successful intercourse?\] = Yes)/(number of attempts with SS where SEP Q3 was answered Yes or No)

    Time frame: Week 4 and Week 6

  31. Mean Per-Patient Percentage of Grade 1 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation- Change From Baseline

    Mean change: mean change at each visit minus mean at baseline. Percent of Grade 1 (1=increase in size, but not hard) erection hardness based on occasions: 100\*(number of occasions where Erection Hardness Scale Answer 1)/(number of occasions where Erection Hardness Scale was answered)

    Time frame: Week 2, Week 4 and Week 6

  32. Mean Per-Patient Percentage of Grade 1 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation- Change From Week 2

    Mean change: mean change at each visit minus mean at Week 2. Percent of Grade 1 (1=increase in size, but not hard) erection hardness based on occasions: 100\*(number of occasions where Erection Hardness Scale Answer 1)/(number of occasions where Erection Hardness Scale was answered)

    Time frame: Week 4 and Week 6

  33. Mean Per-Patient Percentage of Grade 2 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation - Change From Baseline

    Mean change: mean change at each visit minus mean at baseline. Percent of Grade 2 (2= hard, but not hard enough for penetration) erection hardness based on occasions: 100\*(number of occasions where Erection Hardness Scale Answer 2)/(number of occasions where Erection Hardness Scale was answered)

    Time frame: Week 2, Week 4 and Week 6

  34. Mean Per-Patient Percentage of Grade 2 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation - Change From Week 2

    Mean change: mean change at each visit minus mean at Week 2. Percent of Grade 2 (2= hard, but not hard enough for penetration) erection hardness based on occasions: 100\*(number of occasions where Erection Hardness Scale Answer 2)/(number of occasions where Erection Hardness Scale was answered)

    Time frame: Week 4 and Week 6

  35. Mean Per-Patient Percentage of Grade 3 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation - Change From Baseline

    Mean change: mean change at each visit minus mean at baseline. Percent of Grade 3 (3= hard enough for penetration \[but not completely hard\]) erection hardness based on occasions: 100\*(number of occasions where Erection Hardness Scale Answer 3)/(number of occasions where Erection Hardness Scale was answered)

    Time frame: Week 2, Week 4 and Week 6

  36. Mean Per-Patient Percentage of Grade 3 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation - Change From Week 2

    Mean change: mean change at each visit minus mean at Week 2. Percent of Grade 3 (3= hard enough for penetration \[but not completely hard\]) erection hardness based on occasions: 100\*(number of occasions where Erection Hardness Scale Answer 3)/(number of occasions where Erection Hardness Scale was answered)

    Time frame: Week 4 and Week 6

  37. Mean Per-Patient Percentage of Grade 4 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation - Change From Baseline

    Mean change: mean change at each visit minus mean at baseline. Percent of Grade 4 (4= completely hard) erection hardness based on occasions: 100\*(number of occasions where Erection Hardness Scale Answer 4)/(number of occasions where Erection Hardness Scale was answered)

    Time frame: Week 2, Week 4 and Week 6

  38. Mean Per-Patient Percentage of Grade 4 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation - Change From Week 2

    Mean change: mean change at each visit minus mean at Week 2. Percent of Grade 4 (4= completely hard) erection hardness based on occasions: 100\*(number of occasions where Erection Hardness Scale Answer 4)/(number of occasions where Erection Hardness Scale was answered)

    Time frame: Week 4 and Week 6

  39. Mean Per-Patient Percentage of Grade 3 or 4 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation - Change From Baseline

    Mean change: mean change at each visit minus mean at baseline. Percent of Grade 3 (hard enough for penetration \[but not completely hard\]) or 4 (completely hard) erection hardness based on occasions: 100\*(number of occasions where Erection Hardness Scale Answer 3 or 4)/ (number of occasions where Erection Hardness Scale was answered)

    Time frame: Week 2, Week 4 and Week 6

  40. Mean Per-Patient Percentage of Grade 3 or 4 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation - Change From Week 2

    Mean change: mean change at each visit minus mean at Week 2. Percent of Grade 3 (hard enough for penetration \[but not completely hard\]) or 4 (completely hard) erection hardness based on occasions: 100\*(number of occasions where Erection Hardness Scale Answer 3 or 4)/ (number of occasions where Erection Hardness Scale was answered)

    Time frame: Week 4 and Week 6

07

Results

Posted Mar 16, 2009

Participant flow

Participant flow — Overall Study
MilestoneOpen Label Sildenafil Citrate
Started117
Completed110
Not completed7
Withdrew: Lost to follow-up4
Withdrew: Withdrawal by subject2
Withdrew: Protocol violation1

Outcome measures

PrimaryInternational Index of Erectile Function (IIEF), Erectile Function (EF) Domain Score- Change From Baseline to Week 6 Last Observation Carried Forward (LOCF)

IIEF is a self-administered scale designed to assess erectile functioning: includes 15 questions on 5 relevant domains of male sexual function; one is erectile function (EF). IIEF-EF Domain: sum of scores for Questions 1, 2, 3, 4, 5 \& 15 from IIEF. Score range: 0 to 5 (Q1 to Q5), 1 to 5 (Q15); total 1 to 30. Higher score indicates better outcome.

Time frame:
Week 6 LOCF
Reported as:
Mean · score on scale
International Index of Erectile Function (IIEF), Erectile Function (EF) Domain Score- Change From Baseline to Week 6 Last Observation Carried Forward (LOCF)
score on scaleOpen Label Sildenafil Citrate
International Index of Erectile Function (IIEF), Erectile Function (EF) Domain Score- Change From Baseline to Week 6 Last Observation Carried Forward (LOCF)10.96 ± 5.19
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (Statistical significance will be declared if the p-value is \<0.05. Change from Baseline: Week 6 (LOCF) minus Baseline) · Mean difference (net): 10.96 · 95% CI 10.00 to 11.93single sample t-test
SecondaryInternational Index of Erectile Function (IIEF), Erectile Function (EF) Domain Score - Change From Baseline at Weeks 2, 4 and 6

IIEF is a self-administered scale designed to assess erectile functioning: includes 15 questions on 5 relevant domains of male sexual function; one is erectile function (EF). IIEF-EF Domain: sum of scores for Questions 1, 2, 3, 4, 5 \& 15 from IIEF. Score range: 0 to 5 (Q1 to Q5), 1 to 5 (Q15); total 1 to 30. Higher score indicates better outcome.

Time frame:
Week 2, Week 4 and Week 6
Reported as:
Mean · score on a scale
International Index of Erectile Function (IIEF), Erectile Function (EF) Domain Score - Change From Baseline at Weeks 2, 4 and 6
score on a scaleOpen Label Sildenafil Citrate
Week 2 (N=113)7.14 ± 5.21
Week 4 (N=112)10.57 ± 5.43
Week 6 (N=110)10.93 ± 5.26
Week 6 Endpoint (N=112)10.95 ± 5.21
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 7.14 · 95% CI 6.17 to 8.11single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 10.57 · 95% CI 9.56 to 11.59single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 10.93 · 95% CI 9.93 to 11.92single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 10.95 · 95% CI 9.97 to 11.92single sample t-test
SecondaryInternational Index of Erectile Function (IIEF), Erectile Function (EF) Domain Score- Change From Week 2

IIEF is a self-administered scale designed to assess erectile functioning: includes 15 questions on 5 relevant domains of male sexual function; one is erectile function (EF). IIEF-EF Domain: sum of scores for Questions 1, 2, 3, 4, 5 \& 15 from IIEF. Score range: 0 to 5 (Q1 to Q5), 1 to 5 (Q15); total 1 to 30. Higher score indicates better outcome.

Time frame:
Week 4 and Week 6
Reported as:
Mean · score on scale
International Index of Erectile Function (IIEF), Erectile Function (EF) Domain Score- Change From Week 2
score on scaleOpen Label Sildenafil Citrate
Week 4 (N=112)3.48 ± 3.97
Week 6 (N=110)3.88 ± 4.38
Week 6 LOCF (N=112)3.86 ± 4.35
Week 6 Endpoint (N=112)3.86 ± 4.35
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 3.48 · 95% CI 2.74 to 4.23single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 3.88 · 95% CI 3.05 to 4.71single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 3.86 · 95% CI 3.04 to 4.67single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 3.86 · 95% CI 3.04 to 4.67single sample t-test
SecondaryInternational Index of Erectile Function (IIEF), Orgasmic Function Domain- Change From Baseline

IIEF is a self-administered scale to assess erectile functioning. IIEF includes 15 questions and addresses the 5 relevant domains of male sexual function, one is orgasmic function. IIEF Orgasmic Function Domain was sum of scores for Questions 9 and 10 from the IIEF. Score range: 0 to 5; total 0 to 10. Higher score indicates better outcome.

Time frame:
Week 2, Week 4 and Week 6
Reported as:
Mean · score on scale
International Index of Erectile Function (IIEF), Orgasmic Function Domain- Change From Baseline
score on scaleOpen Label Sildenafil Citrate
Week 2 (N=113)1.89 ± 2.40
Week 4 (N=112)2.46 ± 2.32
Week 6 (N=110)2.59 ± 2.44
Week 6 LOCF (N=113)2.63 ± 2.45
Week 6 Endpoint (N=112)2.59 ± 2.42
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for significance p\<0.05) · Mean difference (net): 1.89 · 95% CI 1.45 to 2.34single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 2.46 · 95% CI 2.02 to 2.89single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 2.59 · 95% CI 2.13 to 3.05single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 2.63 · 95% CI 2.17 to 3.08single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 2.59 · 95% CI 2.14 to 3.04single sample t-test
SecondaryInternational Index of Erectile Function (IIEF), Orgasmic Function Domain- Change From Week 2

IIEF is a self-administered scale to assess erectile functioning. IIEF includes 15 questions and addresses the 5 relevant domains of male sexual function, one is orgasmic function. IIEF Orgasmic Function Domain was sum of scores for Questions 9 and 10 from the IIEF. Score range: 0 to 5; total 0 to 10. Higher score indicates better outcome.

Time frame:
Week 4 and Week 6
Reported as:
Mean · score on scale
International Index of Erectile Function (IIEF), Orgasmic Function Domain- Change From Week 2
score on scaleOpen Label Sildenafil Citrate
Week 4 (N=112)0.61 ± 1.51
Week 6 (N=110)0.75 ± 1.46
Week 6 LOCF (N=112)0.74 ± 1.45
Week 6 Endpoint (N=112)0.74 ± 1.45
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 0.61 · 95% CI 0.32 to 0.89single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 0.75 · 95% CI 0.47 to 1.02single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 0.74 · 95% CI 0.47 to 1.01single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 0.74 · 95% CI 0.47 to 1.01single sample t-test
SecondaryInternational Index of Erectile Function (IIEF), Sexual Desire Domain Score- Change From Baseline

IIEF is a self-administered scale to assess erectile functioning. IIEF includes 15 questions and addresses the 5 relevant domains of male sexual function, one of which is sexual desire. IIEF Sexual Desire Domain was sum of scores for Questions 11 and 12 from the IIEF. Score range: 1 to 5; total 2 to 10. Higher score indicates better outcome.

Time frame:
Week 2, Week 4 and Week 6
Reported as:
Mean · score on scale
International Index of Erectile Function (IIEF), Sexual Desire Domain Score- Change From Baseline
score on scaleOpen Label Sildenafil Citrate
Week 2 (N=113)1.43 ± 1.87
Week 4 (N=112)2.00 ± 1.86
Week 6 (N=110)2.25 ± 1.91
Week 6 LOCF (N=113)2.26 ± 1.94
Week 6 Endpoint (N=112)2.28 ± 1.93
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 1.43 · 95% CI 1.09 to 1.78single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 2.00 · 95% CI 1.65 to 2.35single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 2.25 · 95% CI 1.89 to 2.62single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 2.26 · 95% CI 1.90 to 2.62single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 2.28 · 95% CI 1.91 to 2.64single sample t-test
SecondaryInternational Index of Erectile Function (IIEF), Sexual Desire Domain Score- Change From Week 2

IIEF is a self-administered scale to assess erectile functioning. IIEF includes 15 questions and addresses the 5 relevant domains of male sexual function, one of which is sexual desire. IIEF Sexual Desire Domain was sum of scores for Questions 11 and 12 from the IIEF. Score range: 1 to 5; total 2 to 10. Higher score indicates better outcome.

Time frame:
Week 4 and Week 6
Reported as:
Mean · score on scale
International Index of Erectile Function (IIEF), Sexual Desire Domain Score- Change From Week 2
score on scaleOpen Label Sildenafil Citrate
Week 4 (N=112)0.55 ± 1.41
Week 6 (N=110)0.81 ± 1.47
Week 6 LOCF (N=112)0.83 ± 1.49
Week 6 Endpoint (N=112)0.83 ± 1.49
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 0.55 · 95% CI 0.29 to 0.82single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 0.81 · 95% CI 0.53 to 1.09single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 0.83 · 95% CI 0.55 to 1.11single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 0.83 · 95% CI 0.55 to 1.11single sample t-test
SecondaryInternational Index of Erectile Function (IIEF), Intercourse Satisfaction Domain Score- Change From Baseline

IIEF is a self-administered scale to assess erectile functioning. IIEF includes 15 questions and addresses the 5 relevant domains of male sexual function, one is intercourse satisfaction. IIEF Intercourse Satisfaction Domain: sum of scores for Questions 6, 7 and 8 from IIEF. Score range: 0 to 5; total 0 to 15. Higher score indicates better outcome.

Time frame:
Week 2, Week 4, and Week 6
Reported as:
Mean · score on scale
International Index of Erectile Function (IIEF), Intercourse Satisfaction Domain Score- Change From Baseline
score on scaleOpen Label Sildenafil Citrate
Week 2 (N=113)3.18 ± 2.42
Week 4 (N=112)4.38 ± 2.39
Week 6 (N=110)4.73 ± 2.53
Week 6 LOCF (N=113)4.70 ± 2.52
Week 6 Endpoint (N=112)4.72 ± 2.52
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 3.18 · 95% CI 2.73 to 3.63single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 4.38 · 95% CI 3.94 to 4.83single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 4.73 · 95% CI 4.25 to 5.21single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 4.70 · 95% CI 4.23 to 5.17single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 4.72 · 95% CI 4.25 to 5.19single sample t-test
SecondaryInternational Index of Erectile Function (IIEF), Intercourse Satisfaction Domain Score- Change From Week 2

IIEF is a self-administered scale to assess erectile functioning. IIEF includes 15 questions and addresses the 5 relevant domains of male sexual function, one is intercourse satisfaction. IIEF Intercourse Satisfaction Domain: sum of scores for Questions 6, 7 and 8 from IIEF. Score range: 0 to 5; total 0 to 15. Higher score indicates better outcome.

Time frame:
Week 4 and Week 6
Reported as:
Mean · score on scale
International Index of Erectile Function (IIEF), Intercourse Satisfaction Domain Score- Change From Week 2
score on scaleOpen Label Sildenafil Citrate
Week 4 (N=112)1.20 ± 2.10
Week 6 (N=110)1.54 ± 2.20
Week 6 LOCF (N=112)1.54 ± 2.19
Week 6 Endpoint (N=112)1.54 ± 2.19
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 1.20 · 95% CI 0.80 to 1.59single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 1.54 · 95% CI 1.12 to 1.95single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 1.54 · 95% CI 1.13 to 1.95single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 1.54 · 95% CI 1.13 to 1.95single sample t-test
SecondaryInternational Index of Erectile Function (IIEF), Overall Satisfaction Domain Score- Change From Baseline

IIEF is a self-administered scale to assess erectile functioning. IIEF includes 15 questions and addresses the 5 relevant domains of male sexual function, one is overall satisfaction. IIEF Overall Satisfaction Domain was sum of scores for Questions 13 and 14 from the IIEF. Score range: 1 to 5; total 2 to 10. Higher score indicates better outcome.

Time frame:
Week 2, Week 4 and Week 6
Reported as:
Mean · score on scale
International Index of Erectile Function (IIEF), Overall Satisfaction Domain Score- Change From Baseline
score on scaleOpen Label Sildenafil Citrate
Week 2 (N=113)2.73 ± 2.38
Week 4 (N=112)3.67 ± 2.49
Week 6 (N=110)3.92 ± 2.52
Week 6 LOCF (N=113)3.91 ± 2.53
Week 6 Endpoint (N=112)3.89 ± 2.53
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 2.73 · 95% CI 2.28 to 3.17single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 3.67 · 95% CI 3.20 to 4.14single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 3.92 · 95% CI 3.44 to 4.40single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 3.91 · 95% CI 3.44 to 4.38single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 3.89 · 95% CI 3.42 to 4.37single sample t-test
SecondaryInternational Index of Erectile Function (IIEF), Overall Satisfaction Domain Score- Change From Week 2

IIEF is a self-administered scale to assess erectile functioning. IIEF includes 15 questions and addresses the 5 relevant domains of male sexual function, one is overall satisfaction. IIEF Overall Satisfaction Domain was sum of scores for Questions 13 and 14 from the IIEF. Score range: 1 to 5; total 2 to 10. Higher score indicates better outcome.

Time frame:
Week 4 and Week 6
Reported as:
Mean · score on scale
International Index of Erectile Function (IIEF), Overall Satisfaction Domain Score- Change From Week 2
score on scaleOpen Label Sildenafil Citrate
Week 4 (N=112)0.97 ± 1.88
Week 6 (N=110)1.21 ± 1.92
Week 6 LOCF (N=112)1.20 ± 1.90
Week 6 Endpoint (N=112)1.20 ± 1.90
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 0.97 · 95% CI 0.62 to 1.32single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 1.21 · 95% CI 0.85 to 1.57single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 1.20 · 95% CI 0.84 to 1.55single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 1.20 · 95% CI 0.84 to 1.55single sample t-test
SecondaryQuality of Erection Questionnaire (QEQ): Total Score - Change From Baseline

QEQ is a self-administered scale used to assess erection hardness and overall quality of erections. The QEQ total score is defined as the sum of the scores from QEQ Questions 1-6. Score range: 1 to 5. Higher score indicates better outcome. Raw QEQ score ranges from 6-30 and is transformed onto a 0-100 scale.

Time frame:
Week 2, Week 4, and Week 6
Reported as:
Mean · score on scale
Quality of Erection Questionnaire (QEQ): Total Score - Change From Baseline
score on scaleOpen Label Sildenafil Citrate
Week 2 (N=113)32.71 ± 25.36
Week 4 (N=112)46.21 ± 26.27
Week 6 (N=110)45.53 ± 26.96
Week 6 LOCF (N=113)45.28 ± 27.01
Week 6 Endpoint (N=112)45.05 ± 27.02
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 32.71 · 95% CI 27.98 to 37.43single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 46.21 · 95% CI 41.29 to 51.12single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 45.53 · 95% CI 40.44 to 50.63single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 45.28 · 95% CI 40.25 to 50.31single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 45.05 · 95% CI 39.99 to 50.11single sample t-test
SecondaryQuality of Erection Questionnaire (QEQ): Total Score- Change From Week 2

QEQ is a self-administered scale used to assess erection hardness and overall quality of erections. The QEQ total score is defined as the sum of the scores from QEQ Questions 1-6. Score range: 1 to 5. Higher score indicates better outcome. Raw QEQ score ranges from 6-30 and is transformed onto a 0-100 scale.

Time frame:
Week 4 and Week 6
Reported as:
Mean · score on scale
Quality of Erection Questionnaire (QEQ): Total Score- Change From Week 2
score on scaleOpen Label Sildenafil Citrate
Week 4 (N=112)13.84 ± 21.10
Week 6 (N=110)13.07 ± 24.25
Week 6 LOCF (N=112)12.69 ± 24.26
Week 6 Endpoint (N=112)12.69 ± 24.26
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 13.84 · 95% CI 9.89 to 17.79single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 13.07 · 95% CI 8.49 to 17.65single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 12.69 · 95% CI 8.14 to 17.23single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 12.69 · 95% CI 8.14 to 17.23single sample t-test
SecondarySexual Experience Questionnaire (Sex-Q): Erection Domain - Change From Baseline

Sexual Experience Questionnaire (Sex-Q) is a self-administered questionnaire designed to assess functional, emotional, and social aspects of sexual experience. Sex-Q includes 15 questions. Sex-Q Erection domain: sum of scores for Questions 1, 2, 3, 4, 5 and 6 from the Sex-Q. Score range: 1 to 5; total 6 to 30. Higher score indicates better outcome.

Time frame:
Week 2, Week 4 and Week 6
Reported as:
Mean · score on scale
Sexual Experience Questionnaire (Sex-Q): Erection Domain - Change From Baseline
score on scaleOpen Label Sildenafil Citrate
Week 2 (N=113)5.41 ± 4.40
Week 4 (N=112)8.85 ± 4.96
Week 6 (N=110)9.21 ± 5.19
Week 6 LOCF (N=113)9.28 ± 5.14
Week 6 Endpoint (N=112)9.25 ± 5.15
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 5.41 · 95% CI 4.59 to 6.23single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 8.85 · 95% CI 7.92 to 9.78single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 9.21 · 95% CI 8.23 to 10.19single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 9.28 · 95% CI 8.32 to 10.24single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 9.25 · 95% CI 8.28 to 10.22single sample t-test
SecondarySexual Experience Questionnaire (Sex-Q): Erection Domain- Change From Week 2

Sexual Experience Questionnaire (Sex-Q) is a self-administered questionnaire designed to assess functional, emotional, and social aspects of sexual experience. Sex-Q includes 15 questions. Sex-Q Erection domain: sum of scores for Questions 1, 2, 3, 4, 5 and 6 from the Sex-Q. Score range: 1 to 5; total 6 to 30. Higher score indicates better outcome.

Time frame:
Week 4 and Week 6
Reported as:
Mean · score on scale
Sexual Experience Questionnaire (Sex-Q): Erection Domain- Change From Week 2
score on scaleOpen Label Sildenafil Citrate
Week 4 (N=112)3.51 ± 3.89
Week 6 (N=110)3.91 ± 4.41
Week 6 LOCF (N=112)3.91 ± 4.38
Week 6 Endpoint (N=112)3.91 ± 4.38
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 3.51 · 95% CI 2.78 to 4.24single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 3.91 · 95% CI 3.08 to 4.74single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 3.91 · 95% CI 3.09 to 4.73single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 3.91 · 95% CI 3.09 to 4.73single sample t-test
SecondarySexual Experience Questionnaire (Sex-Q): Satisfaction Domain - Change From Baseline

Sexual Experience Questionnaire (Sex-Q) is a self-administered questionnaire designed to assess functional, emotional, and social aspects of sexual experience. Sex-Q includes 15 questions (q). Sex-Q Satisfaction domain:sum of scores for q 10, 11, 12, 13, 14 and 15 from Sex-Q. Score range:1 to 5; total 6 to 30. Higher score indicates better outcome

Time frame:
Week 2, Week 4, and Week 6
Reported as:
Mean · score on scale
Sexual Experience Questionnaire (Sex-Q): Satisfaction Domain - Change From Baseline
score on scaleOpen Label Sildenafil Citrate
Week 2 (N=113)6.68 ± 4.86
Week 4 (N=112)9.94 ± 5.21
Week 6 (N=108)10.59 ± 5.08
Week 6 LOCF (N=111)10.63 ± 5.03
Week 6 Endpoint (N=110)10.64 ± 5.06
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 6.68 · 95% CI 5.77 to 7.59single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 9.94 · 95% CI 8.96 to 10.91single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 10.59 · 95% CI 9.62 to 11.56single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 10.63 · 95% CI 9.68 to 11.58single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 10.64 · 95% CI 9.68 to 11.59single sample t-test
SecondarySexual Experience Questionnaire (Sex-Q): Satisfaction Domain - Change From Week 2

Sexual Experience Questionnaire (Sex-Q) is a self-administered questionnaire designed to assess functional, emotional, and social aspects of sexual experience. Sex-Q includes 15 questions (q). Sex-Q Satisfaction domain:sum of scores for q 10, 11, 12, 13, 14 and 15 from Sex-Q. Score range:1 to 5; total 6 to 30. Higher score indicates better outcome

Time frame:
Week 4 and Week 6
Reported as:
Mean · score on scale
Sexual Experience Questionnaire (Sex-Q): Satisfaction Domain - Change From Week 2
score on scaleOpen Label Sildenafil Citrate
Week 4 (N=112)3.29 ± 4.10
Week 6 (N=108)4.03 ± 5.09
Week 6 LOCF (N=110)4.01 ± 5.04
Week 6 Endpoint (N=110)4.01 ± 5.04
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 3.29 · 95% CI 2.52 to 4.05single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 4.03 · 95% CI 3.06 to 5.00single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 4.01 · 95% CI 3.06 to 4.96single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 4.01 · 95% CI 3.06 to 4.96single sample t-test
SecondarySexual Experience Questionnaire (Sex-Q): Relationship Domain - Change From Baseline

Sexual Experience Questionnaire (Sex-Q) is a self-administered questionnaire designed to assess functional, emotional, and social aspects of sexual experience. Sex-Q includes 15 questions. Sex-Q Relationship domain was sum of scores for Questions 7, 8 and 9 from the Sex-Q. Score range: 1 to 5; total 3 to 15. Higher score indicates better outcome.

Time frame:
Week 2, Week 4, and Week 6
Reported as:
Mean · score on scale
Sexual Experience Questionnaire (Sex-Q): Relationship Domain - Change From Baseline
score on scaleOpen Label Sildenafil Citrate
Week 2 (N=112)2.79 ± 2.44
Week 4 (N=111)4.23 ± 2.56
Week 6 (N=108)4.74 ± 2.84
Week 6 LOCF (N=111)4.78 ± 2.81
Week 6 Endpoint (N=110)4.76 ± 2.82
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 2.79 · 95% CI 2.33 to 3.24single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 4.23 · 95% CI 3.74 to 4.71single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 4.74 · 95% CI 4.20 to 5.28single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 4.78 · 95% CI 4.25 to 5.31single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 4.76 · 95% CI 4.23 to 5.30single sample t-test
SecondarySexual Experience Questionnaire (Sex-Q): Relationship Domain - Change From Week 2

Sexual Experience Questionnaire (Sex-Q) is a self-administered questionnaire designed to assess functional, emotional, and social aspects of sexual experience. Sex-Q includes 15 questions. Sex-Q Relationship domain was sum of scores for Questions 7, 8 and 9 from the Sex-Q. Score range: 1 to 5; total 3 to 15. Higher score indicates better outcome.

Time frame:
Week 4 and Week 6
Reported as:
Mean · score on scale
Sexual Experience Questionnaire (Sex-Q): Relationship Domain - Change From Week 2
score on scaleOpen Label Sildenafil Citrate
Week 4 (N=112)1.49 ± 1.91
Week 6 (N=109)1.96 ± 2.08
Week 6 LOCF (N=111)1.98 ± 2.07
Week 6 Endpoint (N=111)1.98 ± 2.07
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 1.49 · 95% CI 1.13 to 1.85single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 1.96 · 95% CI 1.57 to 2.36single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 1.98 · 95% CI 1.59 to 2.37single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 1.98 · 95% CI 1.59 to 2.37single sample t-test
SecondaryMean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 1 on Occasions With Sexual Stimulation- Change From Baseline

Mean change: mean change at each visit minus mean at baseline. Percent of "Yes" responses to Question 1 based on occasions (= sexual stimulation): 100\*(number of occasions where SEP Question 1 \[Were you able to achieve at least some erection (some enlargement of the penis)?\] = Yes) / (number of occasions where Question 1 was answered Yes or No)

Time frame:
Week 2, Week 4 and Week 6
Reported as:
Mean · per-patient percentage
Mean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 1 on Occasions With Sexual Stimulation- Change From Baseline
per-patient percentageOpen Label Sildenafil Citrate
Question 1 (Week 2) N=1108.84 ± 28.70
Question 1 (Week 4) N=10810.18 ± 27.51
Question 1 (Week 6) N=10512.29 ± 28.88
Question 1 (Week 6 LOCF) N=11011.96 ± 28.33
Question 1 (Week 6 Endpoint) N=10811.95 ± 28.55
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = 0.0016 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Median difference (net): 8.84 · 95% CI 3.42 to 14.26single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 10.18 · 95% CI 4.93 to 15.43single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 12.29 · 95% CI 6.70 to 17.88single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 11.96 · 95% CI 6.61 to 17.32single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 11.95 · 95% CI 6.51 to 17.40single sample t-test
SecondaryMean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 1 Based on Occasions With Sexual Stimulation- Change From Week 2

Mean change: mean change at each visit minus mean at Week 2. Percent of "Yes" responses to Question 1 based on occasions (= sexual stimulation): 100\*(number of occasions where SEP Question 1 \[Were you able to achieve at least some erection (some enlargement of the penis)?\] = Yes) / (number of occasions where Question 1 was answered Yes or No)

Time frame:
Week 4 and Week 6
Reported as:
Mean · per-patient percentage
Mean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 1 Based on Occasions With Sexual Stimulation- Change From Week 2
per-patient percentageOpen Label Sildenafil Citrate
Question 1 (Week 4) N=1111.37 ± 14.85
Question 1 (Week 6) N=1083.12 ± 14.26
Question 1 (Week 6 LOCF) N=1132.98 ± 13.95
Question 1 (Week 6 Endpoint) N=1113.04 ± 14.07
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = 0.3324 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 1.37 · 95% CI -1.42 to 4.17single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = 0.0249 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 3.12 · 95% CI 0.40 to 5.84single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = 0.0249 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 2.98 · 95% CI 0.37 to 5.58single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = 0.0249 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 3.04 · 95% CI 0.39 to 5.68single sample t-test
SecondaryMean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 2 on Occasions With Sexual Stimulation- Change From Baseline

Mean change: mean change at each visit minus mean at baseline. Percent of "Yes" responses to SEP Question 2 based on occasions (= sexual stimulation): 100\*(number of occasions where SEP Question 2 \["Were you able to insert your penis into your partner's vagina?"\] = "Yes") / (number of occasions where SEP Question 2 was answered "Yes" or "No").

Time frame:
Week 2, Week 4 and Week 6
Reported as:
Mean · per-patient percentage
Mean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 2 on Occasions With Sexual Stimulation- Change From Baseline
per-patient percentageOpen Label Sildenafil Citrate
Question 2 (Week 2) N=10215.37 ± 30.51
Question 2 (Week 4) N=10017.15 ± 32.22
Question 2 (Week 6) N=9718.22 ± 32.44
Question 2 (Week 6 LOCF) N=10217.33 ± 31.87
Question 2 (Week 6 Endpoint) N=10017.68 ± 32.10
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 15.37 · 95% CI 9.38 to 21.36single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 17.15 · 95% CI 10.76 to 23.55single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 18.22 · 95% CI 11.68 to 24.76single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 17.33 · 95% CI 11.07 to 23.59single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 17.68 · 95% CI 11.31 to 24.04single sample t-test
SecondaryMean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 2 on Occasions With Sexual Stimulation- Change From Week 2

Mean change: mean change at each visit minus mean at Week 2. Percent of "Yes" responses to SEP Question 2 based on occasions (= sexual stimulation): 100\*(number of occasions where SEP Question 2 \["Were you able to insert your penis into your partner's vagina?"\] = "Yes") / (number of occasions where SEP Question 2 was answered "Yes" or "No").

Time frame:
Week 4 and Week 6
Reported as:
Mean · per-patient percentage
Mean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 2 on Occasions With Sexual Stimulation- Change From Week 2
per-patient percentageOpen Label Sildenafil Citrate
Question 2 (Week 4) N=1101.46 ± 9.41
Question 2 (Week 6) N=1071.18 ± 12.33
Question 2 (Week 6 LOCF) N=1121.13 ± 12.05
Question 2 (Week 6 Endpoint) N=1101.15 ± 12.16
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = 0.1061 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 1.46 · 95% CI -0.32 to 3.24single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = 0.3237 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 1.18 · 95% CI -1.18 to 3.54single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = 0.3236 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 1.13 · 95% CI -1.13 to 3.38single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = 0.3236 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 1.15 · 95% CI -1.15 to 3.45single sample t-test
SecondaryMean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 3 on Occasions With Sexual Stimulation- Change From Baseline

Mean change: mean change at each visit minus mean at baseline. Percent of "Yes" responses to SEP Question 2 based on occasions (= sexual stimulation): 100\*(number of occasions where SEP Question 3 \[Did your erection last long enough for you to have successful intercourse?\] = Yes) / (number of occasions where SEP Question 3 was answered Yes or No)

Time frame:
Week 2, Week 4 and Week 6
Reported as:
Mean · per-patient percentage
Mean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 3 on Occasions With Sexual Stimulation- Change From Baseline
per-patient percentageOpen Label Sildenafil Citrate
Question 3 (Week 2) N=10256.96 ± 38.93
Question 3 (Week 4) N=10070.78 ± 35.46
Question 3 (Week 6) N=9771.23 ± 35.79
Question 3 (Week 6 LOCF) N=10272.15 ± 35.41
Question 3 (Week 6 Endpoint) N=10071.60 ± 35.55
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 56.96 · 95% CI 49.31 to 64.60single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 70.78 · 95% CI 63.74 to 77.81single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 71.23 · 95% CI 64.02 to 78.45single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 72.15 · 95% CI 65.20 to 79.11single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 71.60 · 95% CI 64.54 to 78.65single sample t-test
SecondaryMean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 3 Based on Occasions With Sexual Stimulation- Change From Week 2

Mean change: mean change at each visit minus mean at Week 2. Percent of "Yes" responses to SEP Question 2 based on occasions (= sexual stimulation): 100\*(number of occasions where SEP Question 3 \[Did your erection last long enough for you to have successful intercourse?\] = Yes) / (number of occasions where SEP Question 3 was answered Yes or No)

Time frame:
Week 4 and Week 6
Reported as:
Mean · per-patient percentage
Mean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 3 Based on Occasions With Sexual Stimulation- Change From Week 2
per-patient percentageOpen Label Sildenafil Citrate
Question 3 (Week 4) N=11013.56 ± 30.89
Question 3 (Week 6) N=10714.25 ± 31.31
Question 3 (Week 6 LOCF) N=11214.51 ± 31.77
Question 3 (Week 6 Endpoint) N=11014.77 ± 32.00
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 13.56 · 95% CI 7.72 to 19.40single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 14.25 · 95% CI 8.25 to 20.25single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 14.51 · 95% CI 8.56 to 20.46single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 14.77 · 95% CI 8.72 to 20.82single sample t-test
SecondaryMean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 4 Based on Occasions With Sexual Stimulation- Change From Baseline

Mean change: mean change at each visit minus mean at baseline. Percent of "Yes" responses to SEP Question 4 based on occasions (= sexual stimulation): 100\*(number of occasions where SEP Question 4 \["Were you satisfied with the hardness of your erection?"\] = "Yes") / (number of occasions where SEP Question 4 was answered "Yes" or "No").

Time frame:
Week 2, Week 4 and Week 6
Reported as:
Mean · per-patient percentage
Mean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 4 Based on Occasions With Sexual Stimulation- Change From Baseline
per-patient percentageOpen Label Sildenafil Citrate
Question 4 (Week 2) N=10258.58 ± 41.24
Question 4 (Week 4) N=10076.29 ± 37.21
Question 4(Week 6) N=9777.69 ± 37.26
Question 4 (Week 6 LOCF) N=10278.79 ± 36.65
Question 4 (Week 6 Endpoint) N=10078.36 ± 36.89
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 58.58 · 95% CI 50.48 to 66.68single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 76.29 · 95% CI 68.90 to 83.67single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 77.69 · 95% CI 70.18 to 85.21single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 78.79 · 95% CI 71.59 to 85.99single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 78.36 · 95% CI 71.04 to 85.68single sample t-test
SecondaryMean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 4 Based on Occasions With Sexual Stimulation- Change From Week 2

Mean change: mean change at each visit minus mean at Week 2. Percent of "Yes" responses to SEP Question 4 based on occasions (= sexual stimulation): 100\*(number of occasions where SEP Question 4 \["Were you satisfied with the hardness of your erection?"\] = "Yes") / (number of occasions where SEP Question 4 was answered "Yes" or "No").

Time frame:
Week 4 and Week 6
Reported as:
Mean · per-patient percentage
Mean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 4 Based on Occasions With Sexual Stimulation- Change From Week 2
per-patient percentageOpen Label Sildenafil Citrate
Question 4 (Week 4) N=11017.90 ± 36.63
Question 4 (Week 6) N=10719.50 ± 36.84
Question 4 (Week 6 LOCF) N=11219.52 ± 36.99
Question 4 (Week 6 Endpoint) N=11019.88 ± 37.23
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 17.90 · 95% CI 10.98 to 24.83single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 19.50 · 95% CI 12.44 to 26.56single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 19.52 · 95% CI 12.59 to 26.45single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 19.88 · 95% CI 12.84 to 26.91single sample t-test
SecondaryMean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 5 Based on Occasions With Sexual Stimulation- Change From Baseline

Mean change: mean change at each visit minus mean at baseline. Percent of "Yes" responses to SEP Question 5 based on occasions (= sexual stimulation): 100\*(number of occasions where SEP Question 5 \["Were you satisfied with this sexual encounter?"\] = "Yes") / (number of occasions where SEP Question 5 was answered "Yes" or "No")

Time frame:
Week 2, Week 4 and Week 6
Reported as:
Mean · per-patient percentage
Mean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 5 Based on Occasions With Sexual Stimulation- Change From Baseline
per-patient percentageOpen Label Sildenafil Citrate
Question 5 (Week 2) N=10157.34 ± 42.60
Question 5 (Week 4) N=10070.72 ± 40.30
Question 5 (Week 6) N=9770.63 ± 40.78
Question 5 (Week 6 LOCF) N=10272.07 ± 40.27
Question 5 (Week 6 Endpoint) N=10071.51 ± 40.48
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 57.34 · 95% CI 48.93 to 65.75single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 70.72 · 95% CI 62.72 to 78.71single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 70.63 · 95% CI 62.41 to 78.85single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 72.07 · 95% CI 64.16 to 79.98single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 71.51 · 95% CI 63.48 to 79.55single sample t-test
SecondaryMean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 5 Based on Occasions With Sexual Stimulation- Change From Week 2

Mean change: mean change at each visit minus mean at Week 2. Percent of "Yes" responses to SEP Question 5 based on occasions (= sexual stimulation): 100\*(number of occasions where SEP Question 5 \["Were you satisfied with this sexual encounter?"\] = "Yes") / (number of occasions where SEP Question 5 was answered "Yes" or "No")

Time frame:
Week 4 and Week 6
Reported as:
Mean · per-patient percentage
Mean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 5 Based on Occasions With Sexual Stimulation- Change From Week 2
per-patient percentageOpen Label Sildenafil Citrate
Question 5 (Week 4) N=10913.10 ± 29.11
Question 5 (Week 6) N=10614.11 ± 32.53
Question 5 (Week 6 LOCF) N=11113.47 ± 31.92
Question 5 (Week 6 Endpoint) N=10913.72 ± 32.16
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 13.10 · 95% CI 7.58 to 18.63single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 14.11 · 95% CI 7.84 to 20.37single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 13.47 · 95% CI 7.47 to 19.47single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 13.72 · 95% CI 7.61 to 19.82single sample t-test
SecondaryMean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 3 (Q3) Based on Attempts With Sexual Stimulation- Change From Baseline

Mean change: mean change at each visit minus mean at baseline. Percent of "Yes" responses to SEP Q3 based on attempts with sexual stimulation (SS): 100\* (number of attempts with SS where SEP Q3 \[Did your erection last long enough for you to have successful intercourse?\] = Yes)/(number of attempts with SS where SEP Q3 was answered Yes or No)

Time frame:
Week 2, Week 4, and Week 6
Reported as:
Mean · per-patient percentage
Mean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 3 (Q3) Based on Attempts With Sexual Stimulation- Change From Baseline
per-patient percentageOpen Label Sildenafil Citrate
Week 2 (N=102)56.96 ± 38.93
Week 4 (N=100)70.78 ± 35.46
Week 6 (N=97)71.23 ± 35.79
Week 6 LOCF (N=102)72.15 ± 35.41
Week 6 Endpoint (N=100)71.60 ± 35.55
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 56.96 · 95% CI 49.31 to 64.60single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 70.78 · 95% CI 63.74 to 77.81single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 71.23 · 95% CI 64.02 to 78.45single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 72.15 · 95% CI 65.20 to 79.11single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 71.60 · 95% CI 64.54 to 78.65single sample t-test
SecondaryMean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 3 (Q3) Based on Attempts With Sexual Stimulation- Change From Week 2

Mean change: mean change at each visit minus mean at Week 2. Percent of "Yes" responses to SEP Q3 based on attempts with sexual stimulation (SS): 100\* (number of attempts with SS where SEP Q3 \[Did your erection last long enough for you to have successful intercourse?\] = Yes)/(number of attempts with SS where SEP Q3 was answered Yes or No)

Time frame:
Week 4 and Week 6
Reported as:
Mean · per-patient percentage
Mean Per-Patient Percentage of 'Yes' Responses to Sexual Encounter Profile (SEP) Question 3 (Q3) Based on Attempts With Sexual Stimulation- Change From Week 2
per-patient percentageOpen Label Sildenafil Citrate
Week 4 (N=110)13.56 ± 30.89
Week 6 (N=107)14.25 ± 31.31
Week 6 LOCF (N=112)14.51 ± 31.77
Week 6 Endpoint (N=110)14.77 ± 32.00
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 13.56 · 95% CI 7.72 to 19.40single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 14.25 · 95% CI 8.25 to 20.25single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 14.51 · 95% CI 8.56 to 20.46single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 14.77 · 95% CI 8.72 to 20.82single sample t-test
SecondaryMean Per-Patient Percentage of Grade 1 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation- Change From Baseline

Mean change: mean change at each visit minus mean at baseline. Percent of Grade 1 (1=increase in size, but not hard) erection hardness based on occasions: 100\*(number of occasions where Erection Hardness Scale Answer 1)/(number of occasions where Erection Hardness Scale was answered)

Time frame:
Week 2, Week 4 and Week 6
Reported as:
Mean · per-patient percentage
Mean Per-Patient Percentage of Grade 1 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation- Change From Baseline
per-patient percentageOpen Label Sildenafil Citrate
Grade 1 (Week 2) N=103-12.58 ± 37.77
Grade 1 (Week 4) N=101-20.55 ± 35.04
Grade 1 (Week 6) N=98-22.53 ± 36.64
Grade 1 (Week 6 LOCF) N=103-21.44 ± 36.06
Grade 1 (Week 6 Endpoint) N=101-21.86 ± 36.29
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = 0.0010 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -12.58 · 95% CI -19.96 to -5.20single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -20.55 · 95% CI -27.47 to -13.64single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -22.53 · 95% CI -29.88 to -15.18single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -21.44 · 95% CI -28.49 to -14.39single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -21.86 · 95% CI -29.03 to -14.70single sample t-test
SecondaryMean Per-Patient Percentage of Grade 1 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation- Change From Week 2

Mean change: mean change at each visit minus mean at Week 2. Percent of Grade 1 (1=increase in size, but not hard) erection hardness based on occasions: 100\*(number of occasions where Erection Hardness Scale Answer 1)/(number of occasions where Erection Hardness Scale was answered)

Time frame:
Week 4 and Week 6
Reported as:
Mean · per-patient percentage
Mean Per-Patient Percentage of Grade 1 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation- Change From Week 2
per-patient percentageOpen Label Sildenafil Citrate
Grade 1 (Week 4) N=110-6.79 ± 22.58
Grade 1 (Week 6) N=107-6.85 ± 23.02
Grade 1 (Week 6 LOCF) N=112-7.43 ± 24.20
Grade 1 (Week 6 Endpoint) N=110-7.57 ± 24.40
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = 0.0021 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -6.79 · 95% CI -11.06 to -2.52single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = 0.0027 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -6.85 · 95% CI -11.26 to -2.43single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = 0.0015 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -7.43 · 95% CI -11.97 to -2.90single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = 0.0015 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -7.57 · 95% CI -12.18 to -2.96single sample t-test
SecondaryMean Per-Patient Percentage of Grade 2 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation - Change From Baseline

Mean change: mean change at each visit minus mean at baseline. Percent of Grade 2 (2= hard, but not hard enough for penetration) erection hardness based on occasions: 100\*(number of occasions where Erection Hardness Scale Answer 2)/(number of occasions where Erection Hardness Scale was answered)

Time frame:
Week 2, Week 4 and Week 6
Reported as:
Mean · Per-patient percentage
Mean Per-Patient Percentage of Grade 2 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation - Change From Baseline
Per-patient percentageOpen Label Sildenafil Citrate
Grade 2 (Week 2) N=103-9.87 ± 34.44
Grade 2 (Week 4) N=101-11.74 ± 32.80
Grade 2 (Week 6) N=98-12.78 ± 33.56
Grade 2 (Week 6 LOCF) N=103-13.13 ± 33.94
Grade 2 (Week 6 Endpoint) N=101-12.40 ± 33.13
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = 0.0045 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -9.87 · 95% CI -16.60 to -3.14single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -11.74 · 95% CI -18.22 to -5.27single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -12.78 · 95% CI -19.51 to -6.05single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -13.13 · 95% CI -19.76 to -6.50single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -12.40 · 95% CI -18.94 to -5.86single sample t-test
SecondaryMean Per-Patient Percentage of Grade 2 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation - Change From Week 2

Mean change: mean change at each visit minus mean at Week 2. Percent of Grade 2 (2= hard, but not hard enough for penetration) erection hardness based on occasions: 100\*(number of occasions where Erection Hardness Scale Answer 2)/(number of occasions where Erection Hardness Scale was answered)

Time frame:
Week 4 and Week 6
Reported as:
Mean · per-patient percentage
Mean Per-Patient Percentage of Grade 2 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation - Change From Week 2
per-patient percentageOpen Label Sildenafil Citrate
Grade 2 (Week 4) N=110-2.39 ± 22.00
Grade 2 (Week 6) N=107-1.91 ± 20.73
Grade 2 (Week 6 LOCF) N=112-2.71 ± 22.28
Grade 2 (Week 6 Endpoint) N=110-2.76 ± 22.48
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = 0.2567 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -2.39 · 95% CI -6.55 to 1.77single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = 0.3435 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -1.91 · 95% CI -5.88 to 2.07single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = 0.2000 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -2.71 · 95% CI -6.89 to 1.46single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = 0.2000 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -2.76 · 95% CI -7.01 to 1.48single sample t-test
SecondaryMean Per-Patient Percentage of Grade 3 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation - Change From Baseline

Mean change: mean change at each visit minus mean at baseline. Percent of Grade 3 (3= hard enough for penetration \[but not completely hard\]) erection hardness based on occasions: 100\*(number of occasions where Erection Hardness Scale Answer 3)/(number of occasions where Erection Hardness Scale was answered)

Time frame:
Week 2, Week 4 and Week 6
Reported as:
Mean · per-patient percentage
Mean Per-Patient Percentage of Grade 3 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation - Change From Baseline
per-patient percentageOpen Label Sildenafil Citrate
Grade 3 (Week 2) N=103-10.82 ± 56.75
Grade 3 (Week 4) N=101-29.16 ± 59.81
Grade 3 (Week 6) N=98-30.79 ± 60.90
Grade 3 (Week 6 LOCF) N=103-30.27 ± 61.70
Grade 3 (Week 6 Endpoint) N=101-30.87 ± 60.54
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = 0.0558 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -10.82 · 95% CI -21.91 to 0.27single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -29.16 · 95% CI -40.96 to -17.35single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -30.79 · 95% CI -43.00 to -18.58single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -30.27 · 95% CI -42.33 to -18.21single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -30.87 · 95% CI -42.82 to -18.92single sample t-test
SecondaryMean Per-Patient Percentage of Grade 3 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation - Change From Week 2

Mean change: mean change at each visit minus mean at Week 2. Percent of Grade 3 (3= hard enough for penetration \[but not completely hard\]) erection hardness based on occasions: 100\*(number of occasions where Erection Hardness Scale Answer 3)/(number of occasions where Erection Hardness Scale was answered)

Time frame:
Week 4 and Week 6
Reported as:
Mean · per-patient percentage
Mean Per-Patient Percentage of Grade 3 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation - Change From Week 2
per-patient percentageOpen Label Sildenafil Citrate
Grade 1 (Week 4) N=110-18.36 ± 46.03
Grade 1 (Week 6) N=107-22.16 ± 45.24
Grade 1 (Week 6 LOCF) N=112-20.28 ± 45.86
Grade 1 (Week 6 Endpoint) N=110-20.65 ± 46.20
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Median difference (net): -18.36 · 95% CI -27.05 to -9.66single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -22.16 · 95% CI -30.84 to -13.49single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -20.28 · 95% CI -28.87 to -11.69single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): -20.65 · 95% CI -29.38 to -11.92single sample t-test
SecondaryMean Per-Patient Percentage of Grade 4 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation - Change From Baseline

Mean change: mean change at each visit minus mean at baseline. Percent of Grade 4 (4= completely hard) erection hardness based on occasions: 100\*(number of occasions where Erection Hardness Scale Answer 4)/(number of occasions where Erection Hardness Scale was answered)

Time frame:
Week 2, Week 4 and Week 6
Reported as:
Mean · per-patient percentage
Mean Per-Patient Percentage of Grade 4 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation - Change From Baseline
per-patient percentageOpen Label Sildenafil Citrate
Grade 4 (Week 2) N=10333.27 ± 41.43
Grade 4 (Week 4) N=10161.45 ± 44.77
Grade 4 (Week 6) N=9866.10 ± 45.15
Grade 4 (Week 6 LOCF) N=10364.84 ± 45.70
Grade 4 (Week 6 Endpoint) N=10165.13 ± 45.56
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 33.27 · 95% CI 25.17 to 41.36single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 61.45 · 95% CI 52.61 to 70.29single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 66.10 · 95% CI 57.05 to 75.16single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 64.84 · 95% CI 55.91 to 73.77single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 65.13 · 95% CI 56.14 to 74.12single sample t-test
SecondaryMean Per-Patient Percentage of Grade 4 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation - Change From Week 2

Mean change: mean change at each visit minus mean at Week 2. Percent of Grade 4 (4= completely hard) erection hardness based on occasions: 100\*(number of occasions where Erection Hardness Scale Answer 4)/(number of occasions where Erection Hardness Scale was answered)

Time frame:
Week 4 and Week 6
Reported as:
Mean · per-patient percentage
Mean Per-Patient Percentage of Grade 4 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation - Change From Week 2
per-patient percentageOpen Label Sildenafil Citrate
Grade 4 (Week 4) N=11027.53 ± 40.19
Grade 4 (Week 6) N=10730.92 ± 41.90
Grade 4 (Week 6 LOCF) N=11230.43 ± 41.88
Grade 4 (Week 6 Endpoint) N=11030.98 ± 42.06
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 27.53 · 95% CI 19.94 to 35.13single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 30.92 · 95% CI 22.89 to 38.95single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 30.43 · 95% CI 22.59 to 38.27single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 30.98 · 95% CI 23.04 to 38.93single sample t-test
SecondaryMean Per-Patient Percentage of Grade 3 or 4 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation - Change From Baseline

Mean change: mean change at each visit minus mean at baseline. Percent of Grade 3 (hard enough for penetration \[but not completely hard\]) or 4 (completely hard) erection hardness based on occasions: 100\*(number of occasions where Erection Hardness Scale Answer 3 or 4)/ (number of occasions where Erection Hardness Scale was answered)

Time frame:
Week 2, Week 4 and Week 6
Reported as:
Mean · per-patient percentage
Mean Per-Patient Percentage of Grade 3 or 4 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation - Change From Baseline
per-patient percentageOpen Label Sildenafil Citrate
Grade 3 or 4 (Week 2) N=10322.45 ± 46.10
Grade 3 or 4 (Week 4) N=10132.30 ± 42.15
Grade 3 or 4 (Week 6) N=9835.31 ± 43.52
Grade 3 or 4 (Week 6 LOCF) N=10334.57 ± 43.48
Grade 3 or 4 (Week 6 Endpoint) N=10134.26 ± 43.29
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 22.45 · 95% CI 13.44 to 31.46single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 32.30 · 95% CI 23.97 to 40.62single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 35.31 · 95% CI 26.59 to 44.04single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 34.57 · 95% CI 26.07 to 43.07single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 34.26 · 95% CI 25.72 to 42.81single sample t-test
SecondaryMean Per-Patient Percentage of Grade 3 or 4 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation - Change From Week 2

Mean change: mean change at each visit minus mean at Week 2. Percent of Grade 3 (hard enough for penetration \[but not completely hard\]) or 4 (completely hard) erection hardness based on occasions: 100\*(number of occasions where Erection Hardness Scale Answer 3 or 4)/ (number of occasions where Erection Hardness Scale was answered)

Time frame:
Week 4 and Week 6
Reported as:
Mean · per-patient percentage
Mean Per-Patient Percentage of Grade 3 or 4 Events in Erection Hardness Grading Scale (EHGS) Based on Occasions With Sexual Stimulation - Change From Week 2
per-patient percentageOpen Label Sildenafil Citrate
Grade 3 or 4 (Week 4) N=1109.18 ± 29.45
Grade 3 or 4 (Week 6) N=1078.75 ± 29.26
Grade 3 or 4 (Week 6 LOCF ) N=11210.15 ± 31.11
Grade 3 or 4 (Week 6 Endpoint ) N=11010.33 ± 31.36
Statistical analysis
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = 0.0014 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 9.18 · 95% CI 3.61 to 14.74single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = 0.0025 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 8.75 · 95% CI 3.15 to 14.36single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 10.15 · 95% CI 4.32 to 15.97single sample t-test
  • Open Label Sildenafil Citrate · t-test, 2 sided · p = <0.001 (p-value not adjusted for multiple comparisons. Threshold for statistical significance p\<0.05) · Mean difference (net): 10.33 · 95% CI 4.41 to 16.26single sample t-test

Adverse events

Non-serious events are listed at a 1.70% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Open Label Sildenafil Citrate—0/117 (0%)—
Most frequent other events
Most frequent other events
EventOpen Label Sildenafil Citrate
HeadacheNervous system disorders18/117
Hot FlushVascular disorders10/117
Nasal CongestionRespiratory, thoracic and mediastinal disorders3/117
FlushingVascular disorders3/117
GastritisGastrointestinal disorders3/117

Baseline characteristics

Age, Continuous
Age, Continuous(years)Open Label Sildenafil Citrate
Mean53.3 ± 11
Sex: Female, Male
Sex: Female, Male(Participants)Open Label Sildenafil Citrate
Female0
Male117
08

Study locations

10 sites
  • Pfizer Investigational Site
    Mexico, D.f. 11520, Mexico
  • Pfizer Investigational Site
    Mexico, D.f. 11850, Mexico
  • Pfizer Investigational Site
    Mexico, DF 11850, Mexico
  • Pfizer Investigational Site
    Mexico, Distrito Federal 11850, Mexico
  • Pfizer Investigational Site
    Naucalpan, Edo. De México 53100, Mexico
  • Pfizer Investigational Site
    Zapopan, Jalisco 45040, Mexico
  • Pfizer Investigational Site
    Zapopan, Jalisco 45200, Mexico
  • Pfizer Investigational Site
    Aguascalientes, 20000, Mexico
  • Pfizer Investigational Site
    Durango, 34300, Mexico
  • Pfizer Investigational Site
    Naucalpan Edo. De Mexico, Mexico
09

References and documents

10

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jun 2007, a primary completion of Feb 2008 and a completion of Feb 2008. It does not say whether these dates are actual or estimated.

Results were first posted in Mar 2009, 1 year 1 month after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
May 1, 2007
First posted
May 3, 2007
Start
Jun 2007
Primary completionActual
Feb 2008
CompletionActual
Feb 2008
Results first posted
Mar 16, 2009
Last update
Feb 18, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 18, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00468650
Responsible party
Sponsor
First posted
May 3, 2007
Start date
Jun 2007
Primary completion
Feb 2008
Completion
Feb 2008
Results posted
Mar 16, 2009
Last update
Feb 18, 2021

Study contacts

Pfizer CT.gov Call Center
study director · Pfizer

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Sildenafil

Start the discussion